Kymera Therapeutics Inc
Monthly Stock Prices Chart
This stock price chart for Kymera Therapeutics Inc, symbol KYMR, Nasdaq Stock Exchange is updated
monthly. TradingCharts.com offers over 30 thousand free stock price charts and stock market quotes.
[Add symbol to "MyMenu"]
Daily and Weekly charts are also available for Kymera Therapeutics Inc.
Most Recent HeadlinesMNA: Jun 1st, 2024, 20:17Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 19:07Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 18:23Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 17:34Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 16:39Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 15:46Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 15:01Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 14:16Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 13:23Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
MNA: Jun 1st, 2024, 12:28Length: 12115 Kymera Therapeutics Presents New Clinical Data From Ongoing Phase 1 Trial Of MDM2 Degrader KT-253 At ASCO Annual Meeting
|